PD-017Clinical and molecular determinants of extrahepatic disease progression (ePD) in initially unresectable, liver-limited metastatic colorectal cancer (mCRC)

Introduction: In the last years, the availability of active upfront systemic regimens, the development of surgical techniques and the diffusion of other locoregional treatments increased the therapeutic options for mCRC patients with liver-limited disease. Estimating the likelihood to develop extra-hepatic metastases may affect clinicians ’ attitudes towards locoregional procedures. No tools to predict the probability of ePD of initially liver limited mCRC are currently available.  
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research